The webinar will educate on cholangiocarcinoma disease state, as well as summarize the clinical data that supports the agents that currently comprise the standard of care in the front-line and second-line setting. Additionally, emerging targets of interest and available clinical data will be shared for those agents which are currently under clinical investigation.
7 июл 2024